Objective It is estimated that up to 75% of patients with severe mental illness (SMI) also have
substance use disorder (SUD). The aim of this systematic review was to explore the scope …

Opioid use disorder is classified as a chronic recurrent disease of the central nervous
system (CNS) which leads to personality disorders, co-morbidities and premature death. It …

Psychiatric disorders share neurobiology and frequently co-occur. This neurobiological and
clinical overlap highlights opportunities for transdiagnostic treatments. In this study, we used …

Background Unintentional drug overdoses have reached epidemic levels in the US This
study tests the hypothesis that people who have used non-prescribed buprenorphine more …

Concurrent disorder refers to a diverse set of combinations of substance use disorders and
mental disorders simultaneously in need of treatment. Concurrent disorders are …

Aims To estimate the treated prevalence of mental illness, substance use disorder (SUD)
and dual diagnosis and the association between dual diagnosis and fatal and non‐fatal …

Background: Twelve separate streams of empirical data make a strong case for cannabis-
induced accelerated aging including hormonal, mitochondriopathic, cardiovascular …

As global interest in the therapeutic potential of cannabis and its' derivatives for the
management of selected diseases increases, it is increasingly imperative that the toxic …

Since 2015, the United Nations Office on Drugs and Crime (UNODC)–World Health
Organization (WHO) Informal Scientific Network has strived to bring the voice of science as it …

Recent European data facilitate an epidemiological investigation of the controversial
cannabis–cancer relationship. Of particular concern were prior findings associating high …